LDS/Medical Tests/Platelet Function Analysis

Platelet Function Analysis

Platelets, or thrombocytes, are produced in bone marrow from cells called megakaryocytes. They are non-DNA containing cell fragments that play a large part in blood coagulation, particularly arterial bleeding. Platelet abnormalities fall into two categories, qualitative and quantitative. Thrombocytopenia (decreased platelets) and thrombocytosis (increased platelets) are quantitative disorders that can usually be diagnosed by automated analysis of a blood sample or from a blood smear. When these tests are unable to confirm a diagnosis of a platelet disorder, a qualitative disorder can be suspected.

A platelet function test or platelet aggregation test can be performed to determine the cause of the platelet dysfunction. Normal platelet function allows platelets to aggregate in the body normally during the hemostasis process. Testing platelets in an in vitro environment, although difficult, can aid determination of platelet disorders. Platelets will aggregate under certain conditions and in the presence of certain reagents. Aggregometry involves mixing platelets with "agonists" including ADP, epinephrine, collagen, arachidonic acid, and ristocetin and then observing aggregation patterns. When abnormalities are detected, the testing is repeated to determine if there is a true abnormality. If the results are consistent with impaired platelet function, hereditary bleeding disorders may be confirmed or an extensive review of the patient’s medications can be performed to evaluate for drug-induced abnormaility. Abnormal platelet function can be seen in congenital and acquired disorders such as von Willebrand disease, acute and chronic leukemias, myeloproliferative disorders, myelophthisic processes, and multiple myeloma.

  • Diagnostically useful in the assessment of platelet function
  • In diagnosis of inherited abnormality of platelet function
  • As an aid in diagnosis of von Willebrand disease

Abnormal in:

  • Inherited or acquired abnormality of platelet function
  • Inherited abnormalities including Von Willebrand disease (vWD), Hermansky-Pudlak syndrome, Chediak-Higashi syndrome, Wiskott-Aldrich syndrome, Thrombocytopenia with Absent Radius (TAR) syndrome, Gray platelet syndrome, Glycogen storage disease type 1, Glanzmann thrombasthenia, Bernard-Soulier disease
  • Cyclooxygenase deficiency
  • Possibly in acute and chronic leukemias
  • Possibly in myeloproliferative and myelodysplastic disorders
  • Valvular heart disease, renal insufficiency (uremia)
  • DIC
  • Possibly with Paraproteinemia
  • Certain drugs including aspirin, NSAIDS, anti-platelet drugs such as Plavix
  • Possibly with collagen-vascular disorders, e.g., Marfan's syndrome and Osteogenesis imperfecta.
  • Possibly with Familial thrombocytopenia

Note: Increases in both epinephrine and ADP: most likely abnormal platelet function, (vWD). Increase in epinephrine only: most likely aspirin interference.

Collagen/Epinephrine Closure Time: 57-198 seconds

Collagen/ADP Closure Time: 51-119 seconds

 

 

Closure Time methodology via platelet activation triggered by attachment to collagen.

Whole Blood Citrate (Light Blue) or EDT (lavender).

Stability

  • Ambient: 24 hours
  • Refrigerated: 1-3 days
  • Frozen: 30 days
Activated Partial Thromboplastin Time, Platelet Count, Prothrombin Time, von Willebrand Factor, CBC, Serum Protein Electrophoresis, Flow cytometry, Immunofluorescence, Electron microscopy.

1-3 days. 

Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Haemophilia. 2012 Jul;18 Suppl 4:154-60. [PMID: 22726100]
  • J Thromb Haemost. 2006;4:312. [PMID: 16420557]
  • J Thromb Haemost. 2006;4:2099. [PMID: 16961628]
  • Jacobs DS and DeMott WR. Laboratory Test Handbook. 5th. Hudson, OH. Lexi-Comp, Inc (2001).
  • Burtis C, Ashwood E, and Bruns D. Fundamentals of Clinical Chemistry. St. Louis: Saunders (2008).
  • http://www.nlm.nih.gov/medlineplus/ency/article/000546.htm